$6.50
-0.02 (-0.31%)
Osiris Therapeutics, Inc. (OSIR)
CAPS Rating:
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

RSS Headlines
Fool UK